Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers
Publication Date Feb 2014
Publisher GBI Research
Product Type Report
Pages 90
Single User License help $ 3500.00
Site User License help $ 7000.00
Corporate User License help $ 10500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers

Summary

GBI Research’s report, “Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers” looks at the market, competitive landscape, and trends for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil
- Information on market size for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets
- Annualized market revenue data forecast to 2019 and company share data for 2012
- Information on the leading technologies of key players: F. Hoffmann-La Roche, LifeScan, Bayer Healthcare, Abbott Laboratories and Arkay

Reasons to buy

- Develop business strategies by understanding the dynamics and developments driving the global glucose monitoring devices market
- Design and enhance your product development, marketing, and sales strategies
- Develop market-entry and market-expansion strategies
- Identify the key players best positioned to take advantage of emerging market opportunities
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return
- Identify, understand and capitalize on the next big thing in the glucose monitoring devices market landscape
- Make more informed business decisions from insightful analysis of the global glucose monitoring devices market and the factors shaping it.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
LifeScan
Bayer Healthcare AG
Abbott Laboratories
Arkay, Inc.

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 12
3 Global Glucose Monitoring Device Market: Device Overview 13
3.1 Glucose Monitoring Devices 13
3.1.1 Blood Glucose Meter 13
3.1.2 Blood Glucose Testing Strips 13
3.1.3 Lancets 13
4 Global Glucose Monitoring Device Market: Market Characterization 14
4.1 Global Glucose Monitoring Device Market, Revenue ($bn), 2005–2012 14
4.2 Glucose Monitoring Device Market, Revenue ($bn), 2012–2019 15
4.3 Glucose Monitoring Device Market, Global, Key Company Shares (%), 2012 16
4.4 Glucose Monitoring Device Market, Key Trends 18
4.4.1 Integrated CGM – Insulin pump Systems 18
4.4.2 New Market Entrants to Change the Market Dynamics 19
4.4.3 Awareness Campaigns and Education Programs Result in Better Prevention and Treatment Plans 20
4.5 Market Dynamics 21
4.5.1 Market Drivers 21
4.5.2 Market Restraints 25
5 Global Glucose Monitoring Device Market: Segment Analysis and Forecasts 27
5.1 Blood Glucose Test Strips Market, Global, Revenue, 2005–2012 27
5.2 Blood Glucose Test Strips Market, Global, Revenue ($bn), 2012–2019 28
5.3 Blood Glucose Meters Market, Global, Revenue ($m), 2005–2012 29
5.4 Blood Glucose Meters Market, Global, Revenue, 2012–2019 30
5.5 Lancets Market, Global, Revenue, 2005–2012 31
5.6 Lancets Market, Global, Revenue ($m), 2012–2019 32
6 Global Glucose Monitoring Device Market: Country Analysis and Forecasts 33
6.1 Glucose Monitoring Device Market: Cross-country Analysis 33
6.2 Historic and Forecast Revenue, by Country 35
6.2.1 Glucose Monitoring Device Market, US, Revenue ($m), 2005–2012 35
6.2.2 Glucose Monitoring Device Market, US, Revenue ($m), 2012–2019 36
6.2.3 Glucose Monitoring Device Market, Japan, Revenue ($m), 2005–2012 37
6.2.4 Glucose Monitoring Device Market, Japan, Revenue ($m), 2012–2019 38
6.2.5 Glucose Monitoring Device Market, Germany, Revenue ($m), 2005–2012 39
6.2.6 Glucose Monitoring Device Market, Germany, Revenue ($m), 2012–2019 40
6.2.7 Glucose Monitoring Device Market, India, Revenue ($m), 2005–2012 41
6.2.8 Glucose Monitoring Device Market, India, Revenue ($m), 2012–2019 42
6.2.9 Glucose Monitoring Device Market, France, Revenue ($m), 2005–2012 43
6.2.10 Glucose Monitoring Device Market, France, Revenue ($m), 2012–2019 44
6.2.11 Glucose Monitoring Device Market, UK, Revenue ($m), 2005–2012 45
6.2.12 Glucose Monitoring Device Market, UK, Revenue ($m), 2012–2019 46
6.2.13 Glucose Monitoring Device Market, Canada, Revenue ($m), 2005–2012 47
6.2.14 Glucose Monitoring Device Market, Canada, Revenue ($m), 2012–2019 48
6.2.15 Glucose Monitoring Device Market, Spain, Revenue ($m), 2005–2012 49
6.2.16 Glucose Monitoring Device Market, Spain, Revenue ($m), 2012–2019 50
6.2.17 Glucose Monitoring Device Market, Italy, Revenue ($m), 2005–2012 51
6.2.18 Glucose Monitoring Device Market, Italy, Revenue ($m), 2012–2019 52
6.2.19 Glucose Monitoring Device Market, China, Revenue ($m), 2005–2012 53
6.2.20 Glucose Monitoring Device Market, China, Revenue ($m), 2012–2019 54
6.2.21 Glucose Monitoring Device Market, Australia, Revenue ($m), 2005–2012 55
6.2.22 Glucose Monitoring Device Market, Australia, Revenue ($m), 2012–2019 56
6.2.23 Glucose Monitoring Device Market, Brazil, Revenue ($m), 2005–2012 57
6.2.24 Glucose Monitoring Device Market, Brazil, Revenue ($m), 2012–2019 58
7 Global Glucose Monitoring Device Market: Reimbursement System 59
7.1 US 60
7.2 Europe 61
7.2.1 Germany 61
7.2.2 France 61
7.2.3 Italy 61
7.2.4 Spain 61
7.2.5 UK 62
7.3 Asia-Pacific 62
8 Global Glucose Monitoring Device Market: Competitive Landscape 63
8.1 Comparison of Key Continuous Glucose Monitoring Systems 64
8.2 F. Hoffmann-La Roche Ltd. 65
8.2.1 Business Overview 65
8.2.2 Marketed Products 65
8.2.3 SWOT Analysis 66
8.3 LifeScan 66
8.3.1 Business Overview 66
8.3.2 Marketed Products 67
8.3.3 SWOT Analysis 67
8.4 Bayer Healthcare AG 68
8.4.1 Business Overview 68
8.4.2 Marketed Products 68
8.4.3 SWOT Analysis 69
8.5 Abbott Laboratories 69
8.5.1 Business Overview 69
8.5.2 Marketed Products 69
8.5.3 SWOT Analysis 70
8.6 Arkay, Inc. 70
8.6.1 Business Overview 70
8.6.2 Marketed Products 70
8.6.3 SWOT Analysis 71
9 Global Glucose Monitoring Device Market: Product Pipeline Analysis 72
9.1 Glucose Monitoring Devices Market: List of Pipeline Products 73
9.2 Glucose Monitoring Devices Market: Profiles of Key Pipeline Products 79
9.2.1 5th Generation Short-Term Sensor 79
9.2.2 Integrated Guardian Real-Time Continuous Glucose Monitoring System 79
9.2.3 OptiScannner 80
9.2.4 EyeSense Blood Glucose Measurement Device 80
9.2.5 MD Watch 80
9.2.6 GlySens Continuous Glucose Sensor 81
9.2.7 IvSCGM Biosensor 81
9.2.8 Dario 82
10 Global Glucose Monitoring Device Market: Consolidation Landscape 83
10.1 Deals Summary (2004–2013) 83
10.2 Key Deals (2008–2012) 83
10.2.1 Roche Diagnostics Distribution Agreement with DexCom 83
10.2.2 Bayer HealthCare Diabetes Care’s Partnership with Medtronic 83
10.2.3 Insulet’s Acquisition of Neighborhood Diabetes 84
10.2.4 EyeSense’s Agreement with Qiagen 84
10.2.5 Bionime and Ypsomed’s Agreement to Market Blood Glucose Monitoring Products 84
10.2.6 ARKRAY’s Distribution Agreement with Nipro 84
10.2.7 Edwards Lifesciences’ Agreement with DexCom 85
11 Appendix 86
11.1 Definitions 86
11.1.1 Blood Glucose Meter 86
11.1.2 Blood Glucose Testing Strips 86
11.1.3 Lancets 86
11.2 Acronyms 86
11.3 Sources 87
11.4 Research Methodology 88
11.4.1 Secondary Research 89
11.4.2 Primary Research 89
11.4.3 Models 89
11.4.4 Forecasts 90
11.4.5 Expert Panels 90
11.5 Contact Us 90
11.6 Disclaimer 90

1.1 List of Tables
Table 1: Glucose Monitoring Device Market, Global, Revenue ($bn), 2005–2012 14
Table 2: Glucose Monitoring Device Market, Global, Revenue ($bn), 2012–2019 15
Table 3: Glucose Monitoring Device Market, Global, Key Company Share (%), 2012 17
Table 4: Glucose Monitoring Devices Market, Global, Key Product Launches, 2011−2012 23
Table 5: Blood Glucose Test Strips Market, Global, Revenue ($bn), 2005–2012 27
Table 6: Blood Glucose Test Strips Market, Global, Revenue Forecast ($bn), 2012–2019 28
Table 7: Blood Glucose Meters Market, Global, Revenue ($m), 2005–2012 29
Table 8: Blood Glucose Meters Market, Global, Revenue ($m), 2012–2019 30
Table 9: Lancets Market, Global, Revenue ($m), 2005–2012 31
Table 10: Lancets Market, Global, Revenue Forecast ($m), 2012–2019 32
Table 11: Glucose Monitoring Devices Market, Global, Cross Country Analysis, CAGR (%), 2005–2019 33
Table 12: Glucose Monitoring Device Market, US, Revenue ($m), 2005–2012 35
Table 13: Glucose Monitoring Device Market, US, Revenue ($m), 2012–2019 36
Table 14: Glucose Monitoring Device Market, Japan, Revenue ($m), 2005–2012 37
Table 15: Glucose Monitoring Device Market, Japan, Revenue ($m), 2012–2019 38
Table 16: Glucose Monitoring Device Market, Germany, Revenue ($m), 2005–2012 39
Table 17: Glucose Monitoring Device Market, Germany, Revenue ($m), 2012–2019 40
Table 18: Glucose Monitoring Device Market, India, Revenue ($m), 2005–2012 41
Table 19: Glucose Monitoring Device Market, India, Revenue ($m), 2012–2019 42
Table 20: Glucose Monitoring Device Market, France, Revenue ($m), 2005–2012 43
Table 21: Glucose Monitoring Device Market, France, Revenue ($m), 2012–2019 44
Table 22: Glucose Monitoring Device Market, UK, Revenue ($m), 2005–2012 45
Table 23: Glucose Monitoring Device Market, UK, Revenue ($m), 2012–2019 46
Table 24: Glucose Monitoring Device Market, Canada, Revenue ($m), 2005–2012 47
Table 25: Glucose Monitoring Device Market, Canada, Revenue ($m), 2012–2019 48
Table 26: Glucose Monitoring Device Market, Spain, Revenue ($m), 2005–2012 49
Table 27: Glucose Monitoring Device Market, Spain, Revenue ($m), 2012–2019 50
Table 28: Glucose Monitoring Device Market, Italy, Revenue ($m), 2005–2012 51
Table 29: Glucose Monitoring Device Market, Italy, Revenue ($m), 2012–2019 52
Table 30: Glucose Monitoring Device Market, China, Revenue ($m), 2005–2012 53
Table 31: Glucose Monitoring Device Market, China, Revenue ($m), 2012–2019 54
Table 32: Glucose Monitoring Device Market, Australia, Revenue ($m), 2005–2012 55
Table 33: Glucose Monitoring Device Market, Australia, Revenue ($m), 2012–2019 56
Table 34: Glucose Monitoring Device Market, Brazil, Revenue ($m), 2005–2012 57
Table 35: Glucose Monitoring Device Market, Brazil, Revenue ($m), 2012–2019 58
Table 36: Roche, Key Marketed Products, 2013 65
Table 37: LifeScan, Key Marketed Products, 2013 67
Table 38: Bayer Healthcare AG, Key Marketed Products, 2013 68
Table 39: Abbott Laboratories, Key Marketed Products, 2013 69
Table 40: Arkray Inc., Key Marketed Products, 2013 70
Table 41: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013a 73
Table 42: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013b 74
Table 43: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013c 75
Table 44: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013d 76
Table 45: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013e 77
Table 46: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013f 78
Table 47: Glucose Monitoring Devices Market, Global, List of Pipeline Products, 2013g 78
Table 48: 5th Generation Short-term Sensor, Product Status, 2013 79
Table 49: Integrated Guardian Real-Time Continuous Glucose Monitoring System, Product Status, 2013 79
Table 50: OptiScannner, Product Status, 2013 80
Table 51: EyeSense Blood Glucose Measurement Device, Product Status, 2013 80
Table 52: MD Watch, Product Status, 2013 80
Table 53: GlySens Continuous Glucose Sensor, Product Status, 2013 81
Table 54: IvSCGM Biosensor, Product Status, 2013 81
Table 55: Dario, Product Status, 2013 82

1.2 List of Figures
Figure 1: Glucose Monitoring Device Market, Timeline for Glucose Monitoring 12
Figure 2: Glucose Monitoring Device Market, Device Overview 13
Figure 3: Glucose Monitoring Device Market, Global, Revenue ($bn), 2005–2012 14
Figure 4: Glucose Monitoring Device Market, Global, Revenue ($bn), 2012–2019 15
Figure 5: Glucose Monitoring Device Market, Global, Key Company Share by Revenue (%), 2012 16
Figure 6: Glucose Monitoring Device Market, Market Trends 18
Figure 7: Glucose Monitoring Market, Global, Leading Integrated CGM-Insulin Pump Systems, 2013 19
Figure 8: Glucose Monitoring Market, EU5, National Policies for Prevention and Treatment of Diabetes, 2013 20
Figure 9: Glucose Monitoring Device Market, Market Dynamics 21
Figure 10: Glucose Monitoring Market, Product Launches, US, 2012–2013 23
Figure 11: Glucose Monitoring Market, US, Clinical Trials Elucidating Effects Of CGM In The Treatment Of Type 1 Diabetes Mellitus, 2010 24
Figure 12: Blood Glucose Test Strips Market, Global, Revenue ($bn), 2005–2012 27
Figure 13: Blood Glucose Test Strips Market, Global, Revenue Forecast ($bn), 2012–2019 28
Figure 14: Blood Glucose Meters Market, Global, Revenue ($m), 2005–2012 29
Figure 15: Blood Glucose Meters Market, Global, Revenue Forecast ($m), 2012–2019 30
Figure 16: Lancets Market, Global, Revenue ($m), 2005–2012 31
Figure 17: Lancets Market, Global, Revenue Forecast ($m), 2012–2019 32
Figure 18: Glucose Monitoring Device Market, Global, Cross-Country Analysis, CAGR (%), 2005–2019 33
Figure 19: Glucose Monitoring Device Market, Top 12 Countries, Number of Diabetes Cases (‘000s), 2011, Mean Diabetes Related Expenditure Per Person with Diabetes ($), 2013, 34
Figure 20: Glucose Monitoring Device Market, US, Revenue ($m), 2005–2012 35
Figure 21: Glucose Monitoring Device Market, US, Revenue ($m), 2012–2019 36
Figure 22: Glucose Monitoring Device Market, Japan, Revenue ($m), 2005–2012 37
Figure 23: Glucose Monitoring Device Market, Japan, Revenue ($m), 2012–2019 38
Figure 24: Glucose Monitoring Device Market, Germany, Revenue ($m), 2005–2012 39
Figure 25: Glucose Monitoring Device Market, Germany, Revenue ($m), 2012–2019 40
Figure 26: Glucose Monitoring Device Market, India, Revenue ($m), 2005–2012 41
Figure 27: Glucose Monitoring Device Market, India, Revenue ($m), 2012–2019 42
Figure 28: Glucose Monitoring Device Market, France, Revenue ($m), 2005–2012 43
Figure 29: Glucose Monitoring Device Market, France, Revenue ($m), 2012–2019 44
Figure 30: Glucose Monitoring Device Market, UK, Revenue ($m), 2005–2012 45
Figure 31: Glucose Monitoring Device Market, UK, Revenue ($m), 2012–2019 46
Figure 32: Glucose Monitoring Device Market, Canada, Revenue ($m), 2005–2012 47
Figure 33: Glucose Monitoring Device Market, Canada, Revenue ($m), 2012–2019 48
Figure 34: Glucose Monitoring Device Market, Spain, Revenue ($m), 2005–2012 49
Figure 35: Glucose Monitoring Device Market, Spain, Revenue ($m), 2012–2019 50
Figure 36: Glucose Monitoring Device Market, Italy, Revenue ($m), 2005–2012 51
Figure 37: Glucose Monitoring Device Market, Italy, Revenue ($m), 2012–2019 52
Figure 38: Glucose Monitoring Device Market, China, Revenue ($m), 2005–2012 53
Figure 39: Glucose Monitoring Device Market, China, Revenue ($m), 2012–2019 54
Figure 40: Glucose Monitoring Device Market, Australia, Revenue ($m), 2005–2012 55
Figure 41: Glucose Monitoring Device Market, Australia, Revenue ($m), 2012–2019 56
Figure 42: Glucose Monitoring Device Market, Brazil, Revenue ($m), 2005–2012 57
Figure 43: Glucose Monitoring Device Market, Brazil, Revenue ($m), 2012–2019 58
Figure 44: Glucose Monitoring Device Market, Reimbursement System in Key Geographies 59
Figure 45: Glucose Monitoring Market, US, Medicare Reimbursement, Coding and Billing, 2013 60
Figure 46: Glucose Monitoring Device Market, Global, Competitive Assessment, 2013 63
Figure 47: Glucose Monitoring Device Market, Global, Heat Map, 2013 64
Figure 48: Glucose Monitoring Devices Market, F. Hoffmann-La Roche Ltd., SWOT Analysis, 2013 66
Figure 49: Glucose Monitoring Devices Market, LifeScan, SWOT Analysis, 2013 67
Figure 50: Glucose Monitoring Devices Market, Bayer Healthcare, SWOT Analysis, 2013 69
Figure 51: Glucose Monitoring Devices Market, Abbott Laboratories, SWOT Analysis, 2013 70
Figure 52: Glucose Monitoring Devices Market, Arkray, Inc., SWOT Analysis, 2013 71
Figure 53: Global Glucose Monitoring Device Market, Pipeline Products Summary, 2013 72
Figure 54: Global Glucose Monitoring Device Market, Deals Summary, 2013 83

Title Date Price
2013 Deep Research Report on China Human Use Rabies Vaccine Industry
By QYResearch
2013 Deep Research Report on China Human Use Rabie Vaccine Industry is a professional and depth research report on China Human Use Rabies Vaccine industry. This report has firstly introduced Human Use ...Read More
Jan 2013 $2000.00
By Netscribes (India) Pvt. Ltd.
May 2012 $0.00
Abdominal Obesity-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abdominal Obesity-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establ ...Read More
$1250.00
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abscess-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the un ...Read More
$1250.00
Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and m ...Read More
$2000.00
Acid Indigestion / Heartburn/ Pyrosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Acid Indigestion / Heartburn/ Pyrosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase II ...Read More
$2000.00
Acinetobacter Infections-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Acinetobacter Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...Read More
$1250.00
Acne And Related Disorders-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Acne And Related Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is ...Read More
$1250.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z